Amgen Inc (AMGN)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 61.53% | 60.48% | 63.30% | 66.37% | 70.02% | 73.59% | 74.16% | 74.93% | 75.66% | 75.78% | 75.75% | 75.21% | 75.16% | 75.42% | 75.34% | 75.62% | 75.77% | 76.73% | 78.23% | 79.91% |
| Operating profit margin | 21.71% | 19.11% | 20.02% | 23.59% | 28.01% | 29.36% | 29.27% | 27.77% | 24.62% | 28.61% | 30.27% | 25.23% | 29.40% | 28.50% | 29.11% | 35.42% | 35.95% | 36.74% | 37.87% | 39.88% |
| Pretax margin | 13.79% | 14.38% | 11.40% | 14.71% | 27.86% | 32.61% | 34.59% | 34.80% | 27.91% | 29.35% | 28.40% | 24.77% | 25.79% | 25.02% | 25.50% | 31.67% | 31.99% | 32.97% | 34.20% | 36.90% |
| Net profit margin | 12.24% | 13.00% | 10.12% | 12.74% | 23.83% | 28.20% | 30.02% | 30.23% | 24.89% | 25.96% | 24.92% | 21.75% | 22.68% | 21.77% | 22.55% | 28.16% | 28.57% | 29.42% | 30.04% | 32.02% |
Amgen Inc's profitability ratios have shown mixed trends over the reported periods. The gross profit margin has exhibited a declining trend from 79.91% on March 31, 2020, to 61.53% on December 31, 2024. This decrease suggests potential challenges in managing the cost of goods sold relative to revenue.
Similarly, the operating profit margin has fluctuated over time, with a noticeable decrease from 37.87% on June 30, 2020, to 21.71% on December 31, 2024. This indicates variations in operating efficiency and cost management during the periods under review.
The pretax margin also witnessed fluctuations, with a notable decline from 34.20% on June 30, 2020, to 13.79% on December 31, 2024. This trend suggests changes in the company's ability to generate profits before accounting for taxes.
Furthermore, the net profit margin displayed volatility, with a decrease from 30.04% on June 30, 2020, to 12.24% on December 31, 2024. This indicates variations in the company's bottom-line profitability and ability to convert revenue into net income.
In conclusion, Amgen Inc's profitability ratios reflect varying levels of operational efficiency and cost management over the reported periods, potentially requiring further analysis to understand the underlying factors driving these trends.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 7.90% | 6.84% | 6.81% | 7.49% | 8.13% | 8.70% | 8.62% | 8.20% | 9.95% | 11.82% | 13.47% | 11.22% | 12.49% | 11.30% | 12.41% | 14.25% | 14.52% | 14.20% | 14.15% | 15.50% |
| Return on assets (ROA) | 4.45% | 4.65% | 3.44% | 4.05% | 6.91% | 8.36% | 8.84% | 8.92% | 10.06% | 10.73% | 11.09% | 9.67% | 9.63% | 8.63% | 9.61% | 11.33% | 11.54% | 11.37% | 11.23% | 12.45% |
| Return on total capital | 132.11% | 91.71% | 96.44% | 134.87% | 160.49% | 150.69% | 171.49% | 208.38% | 263.56% | 268.30% | 388.09% | 1,051.86% | 139.33% | 112.50% | 113.13% | 98.89% | 99.85% | 85.91% | 88.54% | 103.25% |
| Return on equity (ROE) | 69.59% | 56.20% | 52.83% | 74.93% | 107.78% | 98.82% | 117.67% | 148.04% | 178.97% | 187.11% | 271.85% | 624.78% | 87.96% | 68.26% | 69.67% | 75.91% | 77.20% | 67.09% | 68.48% | 80.92% |
Amgen Inc's profitability ratios have shown a declining trend over the reported periods.
1. Operating Return on Assets (Operating ROA) has decreased from a high of 15.50% on March 31, 2020, to 6.84% on September 30, 2024. This indicates a decrease in the company's ability to generate profits from its assets through its core operations.
2. Return on Assets (ROA) has also decreased substantially from 12.45% on March 31, 2020, to 4.45% on December 31, 2024. This reduction signifies a decline in how efficiently the company is utilizing its assets to generate profits.
3. Return on Total Capital shows a fluctuating trend, with a significant spike to 1,051.86% on March 31, 2022, followed by a decline to 91.71% on September 30, 2024. This ratio reflects the company's ability to generate returns for all providers of capital, including both equity and debt.
4. Return on Equity (ROE) follows a similar pattern to the other profitability ratios, starting at 80.92% on March 31, 2020, and dropping to 69.59% on December 31, 2024. This ratio indicates how well the company is generating returns on shareholder equity.
Overall, the declining trend in profitability ratios for Amgen Inc suggests potential challenges in maintaining and increasing profitability levels over the reporting periods. Investors and stakeholders may need to assess the company's strategies for improving profitability moving forward.